IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Apellis Pharmaceuticals, Inc

CUSIP: 037530106 | 1 institutional holders

Quarters

Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2018

venBio Partners L.P.1,790,102
62.0% of portfolio›$23.6K
StyleTurnoverLocationFiled
venBio Partners L.P.
1,790,102$23.6K62.0%N/AN/ASan Francisco, CA2019-02-14